1. Home
  2. NNVC vs NXPL Comparison

NNVC vs NXPL Comparison

Compare NNVC & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.02

Market Cap

22.2M

Sector

Health Care

ML Signal

HOLD

Logo NextPlat Corp

NXPL

NextPlat Corp

HOLD

Current Price

$0.54

Market Cap

19.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNVC
NXPL
Founded
2005
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
22.2M
19.2M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
NNVC
NXPL
Price
$1.02
$0.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
296.3K
33.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
10.00
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$0.43
52 Week High
$2.23
$1.11

Technical Indicators

Market Signals
Indicator
NNVC
NXPL
Relative Strength Index (RSI) 49.00 34.29
Support Level $0.93 $0.53
Resistance Level $1.07 $0.59
Average True Range (ATR) 0.08 0.04
MACD 0.02 -0.01
Stochastic Oscillator 81.82 6.61

Price Performance

Historical Comparison
NNVC
NXPL

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Share on Social Networks: